Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RAPT Therapeutics, Inc. | PRESIDENT AND CEO, Director | Employee Stock Option (right to buy) | 275K | $2.08M | $7.58 | Jan 31, 2024 | Direct |
RAPT Therapeutics, Inc. | PRESIDENT AND CEO, Director | Employee Stock Option (right to buy) | 275K | Nov 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RAPT | RAPT Therapeutics, Inc. | Nov 13, 2024 | 12 | $0 | 4 | Nov 15, 2024 | PRESIDENT AND CEO, Director |
RAPT | RAPT Therapeutics, Inc. | Jan 31, 2024 | 1 | $0 | 4 | Feb 1, 2024 | PRESIDENT AND CEO, Director |
RAPT | RAPT Therapeutics, Inc. | Jan 31, 2023 | 1 | $0 | 4 | Feb 2, 2023 | President and CEO, Director |
RAPT | RAPT Therapeutics, Inc. | Jan 28, 2022 | 1 | $0 | 4 | Feb 14, 2022 | President and CEO, Director |